İnönü University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Malatya, Turkey.
Adnan Menderes Üniversitesi, Faculty of Medicine, Department of Pediatric Allergy & Immunollogy, Aydin, Turkey.
Ann Lab Med. 2019 May;39(3):284-290. doi: 10.3343/alm.2019.39.3.284.
Although Th2 immune activation is predominant in allergic diseases, neopterinlevels and indoleamine 2,3-dioxygenase (IDO)-1 activity (kynurenine:tryptophan ratio), which reflect Th1 immune activity, increase with interferon-gamma (IFN-γ) stimulation. We investigated neopterin, tryptophan, and kynurenine levels as biomarkersof the Th1 immune system activation and changes in IDO-1 activityin children with asthma, allergic rhinitis, and atopic dermatitis, as well as the relationship between these biomarkers and the total IgE level, age, and disease severity.
We divided 205 children (80 girls and 125 boys, four months to 17 years old) into four groups: controls, patients with asthma, patients with allergic rhinitis, and patients with atopic dermatitis. Peripheral venous blood samples were collected. Neopterin levels were determined by an enzyme immunoassay. Tryptophan and kynurenine levels were analyzed using HPLC. IDO-1 enzyme activity was calculated using tryptophan and kynurenine levels. IgE levels were measured. The Mann-Whitney U test, Kruskal-Wallis test, and Conover post-hoc method were used for statistical analysis.
Neopterin, tryptophan, and kynurenine levels were higher and IgE levels and IDO-1 enzyme activity were lower in patients with asthma and allergic rhinitis than in controls (<0.05). Patients with atopic dermatitis showed higher neopterin, tryptophan, and kynurenine levels, higher IDO-1 activity, and lower IgE levels thancontrols (<0.05).
The Th1/Th2 balance is disrupted in children with allergic diseases, concomitant with increased Th1-mediated immune response activation and reduced IgEproduction, which is promoted by Th2-type cytokines.
尽管 Th2 免疫激活在过敏性疾病中占主导地位,但反映 Th1 免疫活性的新蝶呤水平和吲哚胺 2,3-双加氧酶(IDO)-1 活性(犬尿氨酸:色氨酸比值)会随着干扰素-γ(IFN-γ)的刺激而增加。我们研究了哮喘、过敏性鼻炎和特应性皮炎患儿的 Th1 免疫系统激活的生物标志物新蝶呤、色氨酸和犬尿氨酸水平,以及这些生物标志物与总 IgE 水平、年龄和疾病严重程度之间的关系。
我们将 205 名儿童(80 名女孩和 125 名男孩,年龄从四个月到 17 岁)分为四组:对照组、哮喘患者组、过敏性鼻炎患者组和特应性皮炎患者组。采集外周静脉血样。通过酶联免疫吸附试验测定新蝶呤水平。采用高效液相色谱法分析色氨酸和犬尿氨酸水平。使用色氨酸和犬尿氨酸水平计算 IDO-1 酶活性。测定 IgE 水平。采用 Mann-Whitney U 检验、Kruskal-Wallis 检验和 Conover 事后检验进行统计学分析。
与对照组相比,哮喘和过敏性鼻炎患者的新蝶呤、色氨酸和犬尿氨酸水平较高,IgE 水平和 IDO-1 酶活性较低(<0.05)。特应性皮炎患者的新蝶呤、色氨酸和犬尿氨酸水平较高,IDO-1 活性较高,IgE 水平较低(<0.05)。
过敏性疾病患儿的 Th1/Th2 平衡失调,伴有 Th1 介导的免疫反应激活增加和 IgE 产生减少,这是由 Th2 型细胞因子促进的。